Clinical Trial Update: Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion status of a Phase 1/Phase 2 study evaluating lapatinib in combination with docetaxel for HER-2 positive metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED